Suchergebnisse - (Subject:"Ritonavir")

PubPharm (44)

1

Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19

enthalten in: Therapeutic drug monitoring | 2023

von Lemaitre, F. | Budde, K. | Van Gelder, T. | +14

2

Drug-Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis

enthalten in: Therapeutic drug monitoring | 2022

von Huang, Y. | Huang, Y. | Wu, T. | +4

3

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

enthalten in: Therapeutic drug monitoring | 2021

von Chouchana, L. | Boujaafar, S. | Gana, I. | +13

4

Important Interactions of Immunosuppressants With Experimental Therapies for Novel Coronavirus Disease (COVID-19) : How to Act

enthalten in: Therapeutic drug monitoring | 2020

von Zijp, T. | Toren-Wielema, M. | Nannan Panday, P. | +3

CommentOn: N Engl J Med. 2020 May 7;382(19):1787-1799. - PMID 32187464

5

Managing Drug-Drug Interaction Between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil

enthalten in: Therapeutic drug monitoring | 2017

von Lemaitre, F. | Ben Ali, Z. | Tron, C. | +5

6

Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection

enthalten in: Therapeutic drug monitoring | 2016

von Badri, P. | Parikh, A. | Coakley, E. | +4

7

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction

enthalten in: Therapeutic drug monitoring | 2016

von Cattaneo, D. | Riva, A. | Clementi, E. | +2

8

Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment

enthalten in: Therapeutic drug monitoring | 2014

von Khaykin, P. | Kotzerke, P. | Stephan, C. | +7

9

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens

enthalten in: Therapeutic drug monitoring | 2013

von Baroncelli, S. | Villani, P. | Galluzzo, C. | +15

10

Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patients

enthalten in: Therapeutic drug monitoring | 2013

von Martínez-Rebollar, M. | Muñoz, A. | Pérez, I. | +10

1
2
3
4
5
Nächster »
[5]